FI119988B - Sykliset heksapeptidit, joilla on antibioottinen aktiivisuus - Google Patents

Sykliset heksapeptidit, joilla on antibioottinen aktiivisuus Download PDF

Info

Publication number
FI119988B
FI119988B FI971397A FI971397A FI119988B FI 119988 B FI119988 B FI 119988B FI 971397 A FI971397 A FI 971397A FI 971397 A FI971397 A FI 971397A FI 119988 B FI119988 B FI 119988B
Authority
FI
Finland
Prior art keywords
phenyl
alkoxy
substituted
nmr
alkyl
Prior art date
Application number
FI971397A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI971397A0 (fi
FI971397L (fi
Inventor
Hisashi Takasugi
Hidenori Ohki
Akira Yamada
Masaki Tomishima
Original Assignee
Astellas Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26305774&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI119988(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB9420425A external-priority patent/GB9420425D0/en
Priority claimed from GBGB9508745.8A external-priority patent/GB9508745D0/en
Application filed by Astellas Pharma Inc filed Critical Astellas Pharma Inc
Publication of FI971397A0 publication Critical patent/FI971397A0/fi
Publication of FI971397L publication Critical patent/FI971397L/fi
Application granted granted Critical
Publication of FI119988B publication Critical patent/FI119988B/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FI971397A 1994-10-07 1997-04-04 Sykliset heksapeptidit, joilla on antibioottinen aktiivisuus FI119988B (fi)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB9420425A GB9420425D0 (en) 1994-10-07 1994-10-07 New compound
GB9420425 1994-10-07
GBGB9508745.8A GB9508745D0 (en) 1995-04-28 1995-04-28 New compound
GB9508745 1995-04-28
PCT/JP1995/001983 WO1996011210A1 (en) 1994-10-07 1995-09-29 Cyclic hexapeptides having antibiotic activity
JP9501983 1995-09-29

Publications (3)

Publication Number Publication Date
FI971397A0 FI971397A0 (fi) 1997-04-04
FI971397L FI971397L (fi) 1997-05-27
FI119988B true FI119988B (fi) 2009-05-29

Family

ID=26305774

Family Applications (1)

Application Number Title Priority Date Filing Date
FI971397A FI119988B (fi) 1994-10-07 1997-04-04 Sykliset heksapeptidit, joilla on antibioottinen aktiivisuus

Country Status (26)

Country Link
US (2) US6107458A (cs)
EP (1) EP0788511B1 (cs)
JP (2) JP2897427B2 (cs)
KR (1) KR100353303B1 (cs)
CN (1) CN1203089C (cs)
AR (1) AR041770A1 (cs)
AT (1) ATE229541T1 (cs)
AU (1) AU696949B2 (cs)
BR (2) BRPI9504791B8 (cs)
CA (1) CA2202058C (cs)
DE (2) DE69529172T2 (cs)
DK (1) DK0788511T3 (cs)
ES (1) ES2187575T3 (cs)
FI (1) FI119988B (cs)
FR (1) FR08C0028I2 (cs)
HU (1) HU228151B1 (cs)
IL (1) IL115484A (cs)
LU (1) LU91452I2 (cs)
MX (1) MX9702531A (cs)
NL (1) NL300352I2 (cs)
NO (2) NO328483B1 (cs)
OA (1) OA10475A (cs)
PT (1) PT788511E (cs)
RU (1) RU2165423C2 (cs)
TR (1) TR199501229A2 (cs)
WO (1) WO1996011210A1 (cs)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5696084A (en) * 1996-08-16 1997-12-09 Abbott Laboratories Amino-lipopetide antifungal agents
AUPO371596A0 (en) * 1996-11-19 1996-12-12 Fujisawa Pharmaceutical Co., Ltd. New compound
AUPO381496A0 (en) * 1996-11-25 1996-12-19 Fujisawa Pharmaceutical Co., Ltd. New compound
US6291680B1 (en) * 1997-06-18 2001-09-18 Fujisawa Pharmaceutical Co., Ltd. Production process
AU756792B2 (en) * 1998-02-09 2003-01-23 Fujisawa Pharmaceutical Co., Ltd. New compound
JP3561917B2 (ja) * 1998-02-09 2004-09-08 藤沢薬品工業株式会社 新規化合物
US7084279B1 (en) * 1999-02-11 2006-08-01 Emisphere Technologies Inc. Oxadiazole compounds and compositions for delivering active agents
ES2251976T3 (es) * 1999-02-11 2006-05-16 Emisphere Technologies, Inc. Compuestos y composiciones de oxadiazol para aportar agentes activos.
AUPP999799A0 (en) * 1999-04-27 1999-05-20 Fujisawa Pharmaceutical Co., Ltd. New compound
AUPQ066399A0 (en) 1999-05-31 1999-06-24 Fujisawa Pharmaceutical Co., Ltd. Antifungal combination use
TWI233805B (en) * 1999-07-01 2005-06-11 Fujisawa Pharmaceutical Co Stabilized pharmaceutical composition in lyophilized form as antifungal agent
US7166572B1 (en) 1999-07-27 2007-01-23 Aventis Pharma Deutschland Gmbh Cyclohexapeptide compounds, processes for their production and their use as a pharmaceutical
AUPQ462399A0 (en) * 1999-12-13 2000-01-13 Fujisawa Pharmaceutical Co., Ltd. New use
TWI250992B (en) 2000-02-21 2006-03-11 Astellas Pharma Inc Polypeptide compounds for the prophylactic and/or therapeutic treatment of infectious diseases caused by pathogenic microorganisms
ES2191516B1 (es) * 2000-07-28 2005-01-01 Consejo Superior De Investigaciones Cientificas Antibioticos antifungicos de naturaleza peptidica inhibidores de la germinacion y el crecimiento de hongos fitopatogenos.
AUPQ938700A0 (en) * 2000-08-14 2000-09-07 Fujisawa Pharmaceutical Co., Ltd. Antifungal combination use
DE60234812D1 (de) 2001-01-29 2010-02-04 Shionogi & Co Arzneipräparat, das als wirkstoff 5-methyl-1-phenyl-2-(1h)-pyridon enthält
JP2005053782A (ja) * 2001-08-31 2005-03-03 Fujisawa Pharmaceut Co Ltd 環状リポペプチド化合物の新規結晶
IL163666A0 (en) 2002-02-22 2005-12-18 New River Pharmaceuticals Inc Active agent delivery systems and methods for protecting and administering active agents
JP4784093B2 (ja) * 2002-08-08 2011-09-28 アステラス製薬株式会社 イソオキサゾリル安息香酸の製造法
AU2003903205A0 (en) * 2003-06-23 2003-07-10 Fujisawa Pharmaceutical Co., Ltd. New compound
DE602004010915T2 (de) * 2003-07-22 2008-12-11 Theravance, Inc., South San Francisco Verwendung eines antimykotischen echinocandin-mittels in kombination mit einem antibakteriellen glycopeptid-mittel
WO2005026323A2 (en) * 2003-09-05 2005-03-24 Merck & Co., Inc. Stationary phases and a purification process using the stationary phases
EP1669350B1 (en) * 2003-09-22 2012-02-29 Msd K.K. Piperidine derivatives
US7476673B2 (en) * 2003-12-30 2009-01-13 Allergan, Inc. Disubstituted chalcone oximes as selective agonists of RARγ retinoid receptors
CN101198598A (zh) * 2004-05-20 2008-06-11 弗尔德里克斯制药股份有限公司 2-((杂)芳基)-苯并噁唑化合物及其衍生物、组合物以及用于稳定和抑制甲状腺素转运蛋白错重叠的方法
BRPI0515500A (pt) 2004-09-20 2008-07-29 Xenon Pharmaceuticals Inc derivados piridazina para inibição de estearoil-coa-desaturase
US7919496B2 (en) 2004-09-20 2011-04-05 Xenon Pharmaceuticals Inc. Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-CoA desaturase enzymes
AU2005286728A1 (en) 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as mediators of stearoyl-CoA desaturase
TW200626138A (en) 2004-09-20 2006-08-01 Xenon Pharmaceuticals Inc Heterocyclic derivatives and their use as therapeutic agents
CN101083994A (zh) 2004-09-20 2007-12-05 泽农医药公司 杂环衍生物及其用作硬脂酰CoA去饱和酶抑制剂的用途
WO2006034441A1 (en) 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
AR051093A1 (es) 2004-09-20 2006-12-20 Xenon Pharmaceuticals Inc Derivados heterociclicos y su uso como inhibidores de estearoil-coa desaturasa
US9611230B2 (en) * 2004-10-13 2017-04-04 Ptc Therapeutics, Inc. 1,3,4-oxadiazole benzoic acid compounds and their use for nonsense suppression and the treatment of disease
BRPI0611187A2 (pt) 2005-06-03 2010-08-24 Xenon Pharmaceuticals Inc derivados aminotiazàis como inibidores da estearoil-coa desaturase humana
WO2007043400A1 (ja) * 2005-10-07 2007-04-19 Kissei Pharmaceutical Co., Ltd. 含窒素芳香族複素環化合物およびそれを含有する医薬組成物
CN101516387B (zh) * 2006-07-26 2014-06-04 桑多斯股份公司 卡泊芬净制剂
US8853392B2 (en) 2007-06-03 2014-10-07 Vanderbilt University Benzamide mGluR5 positive allosteric modulators and methods of making and using same
CN101820761B (zh) 2007-08-13 2013-09-04 孟山都技术有限责任公司 用于控制线虫的组合物和方法
TW200934507A (en) * 2007-10-29 2009-08-16 Astellas Pharma Inc Polypeptide compounds
US8034806B2 (en) 2007-11-02 2011-10-11 Vanderbilt University Bicyclic mGluR5 positive allosteric modulators and methods of making and using same
US8362050B2 (en) * 2008-06-24 2013-01-29 Irm Llc Compounds and methods for modulating G protein-coupled receptors
US9394340B2 (en) 2009-03-24 2016-07-19 Cadila Healthcare Limited Purification process for lipopeptides
BR112013023531A2 (pt) * 2011-04-04 2016-12-06 Xellia Pharmaceuticals Aps processo de um único vaso para a fabricação de micafungina ou de um sal desta
RS54240B1 (sr) 2011-04-20 2015-12-31 Xellia Pharmaceuticals Aps Postupak za prečišćavanje mikafungina
CN102775476B (zh) 2011-05-12 2015-01-07 上海天伟生物制药有限公司 一种米卡芬净钠盐的制备方法
EP2709609B1 (en) 2011-05-17 2017-10-04 Shionogi & Co., Ltd. Heterocyclic compounds
KR20140069097A (ko) * 2011-09-09 2014-06-09 산도즈 아게 미카펀진 중간체의 제조
CN102627689B (zh) * 2012-03-30 2014-08-06 上海天伟生物制药有限公司 一种环肽类化合物的水合物及其制备方法和用途
CN102627688B (zh) 2012-03-30 2014-12-31 上海天伟生物制药有限公司 一种高纯度环肽化合物及其制备方法和用途
CN102659930B (zh) 2012-03-30 2014-04-23 上海天伟生物制药有限公司 一种高纯度环肽类物质的晶体及其制备方法和用途
JP7109189B2 (ja) * 2014-05-29 2022-07-29 シャンハイ テックウェル バイオファーマシューティカル カンパニー リミテッド シクロペプチド系化合物の組成物およびその製造方法と使用
CN104861044B (zh) * 2014-05-29 2019-03-01 上海天伟生物制药有限公司 一种环肽类化合物的溶剂合物及其制备方法和用途
WO2016056023A2 (en) * 2014-10-07 2016-04-14 Alaparthi Lakshmi Prasad Intermediates and processes to prepare micafungin
CA2937365C (en) 2016-03-29 2018-09-18 F. Hoffmann-La Roche Ag Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same
PL3554474T3 (pl) 2016-12-16 2024-04-15 Baxter International Inc. Kompozycje mykafunginy
EP3485873A1 (en) 2017-11-17 2019-05-22 Cadila Healthcare Limited Stable pharmaceutical injectable compositions of micafungin
CN113087775B (zh) * 2018-05-31 2022-07-08 杭州中美华东制药有限公司 米卡芬净钠新晶型ii及其制备方法
WO2020013116A1 (ja) * 2018-07-10 2020-01-16 京都薬品工業株式会社 Ptp-1b阻害剤およびその用途
CN110734408A (zh) * 2019-10-22 2020-01-31 重庆康乐制药有限公司 一种米卡芬净类衍生物侧链中间体的制备方法
CN115785226A (zh) * 2021-09-09 2023-03-14 上海天伟生物制药有限公司 一种棘白菌素药物杂质及其制备、纯化方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1574603A1 (ru) * 1988-08-11 1990-06-30 Ивановский Химико-Технологический Институт Способ получени мезо-тетраарилоктаметилпорфиринов
IE990233A1 (en) * 1990-06-18 2000-11-15 Fujisawa Pharmaceutical Co New Polypeptide Compound and a Process for Preparation thereof
NZ512085A (en) * 1992-03-19 2003-08-29 Lilly Co Eli Methods employing cyclic peptide antifungal agents

Also Published As

Publication number Publication date
MX9702531A (es) 1997-06-28
DE69529172D1 (de) 2003-01-23
CA2202058A1 (en) 1996-04-18
BR9504791A (pt) 1996-10-22
AR041770A1 (es) 2005-06-01
AU3578095A (en) 1996-05-02
WO1996011210A1 (en) 1996-04-18
FR08C0028I2 (cs) 2009-11-20
BRPI9504791B8 (pt) 2019-12-31
ES2187575T3 (es) 2003-06-16
NO2010016I1 (no) 2010-08-16
NO971544L (no) 1997-06-04
KR970707150A (ko) 1997-12-01
JPH10324695A (ja) 1998-12-08
US6265536B1 (en) 2001-07-24
IL115484A0 (en) 1996-01-19
FI971397A0 (fi) 1997-04-04
NO971544D0 (no) 1997-04-04
LU91452I2 (fr) 2008-08-04
NO2010016I2 (no) 2011-10-17
CN1168675A (zh) 1997-12-24
TR199501229A2 (tr) 1996-07-21
DE122008000025I1 (de) 2008-08-21
HUT77736A (hu) 1998-07-28
ATE229541T1 (de) 2002-12-15
CA2202058C (en) 2007-11-06
HK1004136A1 (en) 1998-11-20
EP0788511B1 (en) 2002-12-11
FI971397L (fi) 1997-05-27
DK0788511T3 (da) 2003-03-31
JP3518665B2 (ja) 2004-04-12
RU2165423C2 (ru) 2001-04-20
AU696949B2 (en) 1998-09-24
US6107458A (en) 2000-08-22
EP0788511A1 (en) 1997-08-13
JPH10507174A (ja) 1998-07-14
IL115484A (en) 2000-07-16
DE69529172T2 (de) 2003-04-17
NL300352I2 (nl) 2008-11-03
JP2897427B2 (ja) 1999-05-31
OA10475A (en) 2002-04-08
FR08C0028I1 (cs) 2008-08-15
NO328483B1 (no) 2010-03-01
DE122008000025I2 (de) 2011-02-17
NL300352I1 (nl) 2008-08-01
HU228151B1 (en) 2012-12-28
BR9504791B1 (pt) 2010-10-05
CN1203089C (zh) 2005-05-25
PT788511E (pt) 2003-04-30
KR100353303B1 (ko) 2003-01-15

Similar Documents

Publication Publication Date Title
FI119988B (fi) Sykliset heksapeptidit, joilla on antibioottinen aktiivisuus
CA2044746C (en) Polypeptide compound and a process for preparation thereof
US5569646A (en) Polypeptide compound and a process for preparation thereof
US6232290B1 (en) Cyclic hexapeptides with antimicrobial activity
NZ511478A (en) Compounds useful in the treatment of inflammatory diseases
WO1993021215A1 (en) Peptides having tachykinin antagonist activity
JP2004526728A (ja) 抗菌活性を有する環状ヘキサペプチド化合物
JP3906690B2 (ja) 環状ヘキサペプチド誘導体
US6743776B2 (en) Cyclohexapeptides having antimicrobial activity
JPH0570495A (ja) 環式ヘキサペプチド化合物
US5952299A (en) Cyclic peptide nuclei and derivatives thereof
JP2005524640A (ja) 新規化合物
US5654400A (en) Process for making peptide compounds having tachykinin antagonistic activity
USH1638H (en) Use of the polypeptide compound
AU2001234095B2 (en) Cyclic hexapeptide derivatives

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: ASTELLAS PHARMA INC.

Free format text: ASTELLAS PHARMA INC.

FG Patent granted

Ref document number: 119988

Country of ref document: FI

SPCF Supplementary protection certificate application filed

Free format text: SPC C20090038

Spc suppl protection certif: C20090038

SPCG Supplementary protection certificate granted

Spc suppl protection certif: 369

Extension date: 20200929

MA Patent expired